Lazard Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,160
| Closed | -$3K | – | 2018 |
|
|
2023
Q4 | $3K | Sell |
4,160
-193
| -4% | -$139 | ﹤0.01% | 2135 |
|
|
2023
Q3 | $3K | Buy |
4,353
+185
| +4% | +$127 | ﹤0.01% | 2187 |
|
|
2023
Q2 | $3K | Sell |
4,168
-15,130
| -78% | -$10.9K | ﹤0.01% | 2220 |
|
|
2023
Q1 | $20K | Sell |
19,298
-79,292
| -80% | -$82.2K | ﹤0.01% | 2050 |
|
|
2022
Q4 | $143K | Buy |
+98,590
| New | +$143K | ﹤0.01% | 1381 |
|
|
2018
Q3 | – | Sell |
-160,892
| Closed | -$1.91M | – | 1044 |
|
|
2018
Q2 | $1.91M | Buy |
160,892
+49,210
| +44% | +$584K | ﹤0.01% | 664 |
|
|
2018
Q1 | $1.25M | Buy |
+111,682
| New | +$1.25M | ﹤0.01% | 687 |
|